Search for dissertations about: "Temozolomide"
Showing result 1 - 5 of 23 swedish dissertations containing the word Temozolomide.
-
1. Pancreatic Endocrine Tumors and GIST - Clinical Markers, Epidemiology and Treatment
Abstract : Pancreatic endocrine tumors and gastrointestinal stromal tumors are rare. Evidence regarding prognostic factors, and in the former also treatment, is scarce. We evaluated the survival and prognostic factors in a consecutive series of 324 patients with pancreatic endocrine tumors treated at a single institution. READ MORE
-
2. Combined chemotherapy and immunotherapy against experimental malignant brain tumors
Abstract : Glioblastoma multiforme (GBM) is the most common and aggressive primary malignant brain tumor in adults. Despite standard treatment including surgery, radiotherapy and temozolomide (TMZ)-based chemotherapy, the prognosis for GBM patients is dismal, and there is a need for novel treatments. READ MORE
-
3. From Genes to Therapy : Modeling and Novel Therapeutic Strategies for Brain Tumors
Abstract : Medulloblastoma is the most common malignant pediatric brain tumor and is molecularly divided into four subgroups – WNT, SHH, Group 3 and Group 4. Two thirds of medulloblastoma patients survive, but survivors often suffer from severe, lifelong side-effects. The MYCN oncogene is deregulated in many medulloblastoma patients. READ MORE
-
4. Epigenetics of paediatric glioma stem cells; focusing on exosomes, miRNAs and DNA methylation
Abstract : Tumours in the central nervous system are accountable for the majority of cancer-related deaths in children. Glioblastoma multiforme, one of the deadliest of the central nervous system tumours, is partly driven by glioma stem cells. The generation and maintenance of these cells is orchestrated by complex genetic and epigenetic mechanisms. READ MORE
-
5. Glioblastoma heterogeneity and plasticity : Investigating the roles of BMP4 and SOX2
Abstract : The malignant primary brain tumor glioblastoma has a dismal prognosis and is distinguished by its heterogeneous character. Current treatment with surgical resection, radiotherapy and adjuvant chemotherapy with the alkylating agent temozolomide does not provide a cure, but simply prolongs survival by a few months. READ MORE